Effects of acute percutaneous transluminal recanalization on cerebral embolism

Acta Neurologica Scandinavica

Volumn 93, Issue SUPPL166, 1996, Pages 99-103

  Takasago, Teiichi ^a   Tsuha, Mitsuru ^b   Nagatsugu, Yoshio ^b   Wakuta, Yukio ^b   Yamashita, Tetsuo ^a  

^a YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Saiseikai Yamaguchi General Hospital   (Japan)

Author keywords

Acetazolamide; Cerebral blood flow; Cerebral embolism; Thrombolysis; Xenon CT

Indexed keywords

ACETAZOLAMIDE; UROKINASE; XENON; CONTRAST MEDIUM; DIAGNOSTIC AGENT;

ADULT; AGED; BLOOD CLOT LYSIS; BRAIN BLOOD FLOW; BRAIN EMBOLISM; BRAIN INFARCTION; BRAIN SCINTISCANNING; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; CONTROLLED STUDY; HEMODYNAMICS; HUMAN; INHALATIONAL DRUG ADMINISTRATION; INTRAARTERIAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; RECANALIZATION; ACUTE DISEASE; ARTICLE; BLOOD FLOW; BLOOD FLOW VELOCITY; BRAIN; BRAIN CORTEX; FEMALE; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PHYSIOLOGY; THROMBOEMBOLISM; TREATMENT OUTCOME; VASCULARIZATION;

ACUTE DISEASE; ADULT; AGED; AGED, 80 AND OVER; ANGIOPLASTY, BALLOON; BLOOD FLOW VELOCITY; BRAIN; CEREBRAL CORTEX; CEREBRAL INFARCTION; CONTRAST MEDIA; FEMALE; HEMODYNAMIC PROCESSES; HUMANS; INTRACRANIAL EMBOLISM AND THROMBOSIS; MALE; MIDDLE AGED; REGIONAL BLOOD FLOW; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; XENON;

EID: 0029687047     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.1996.tb00562.x     Document Type: Article

References (38)

1. Wardlaw JM, Warlow CP. Thrombolysis in acute ischemic stroke: Dose it work Stroke 1992: 23:1826-39.
2. Zanette EM, Roberti C, Mancini G, Pozzilli C, Bragoni M, Toni D. Spontaneous middle cerebral artery reperfusion in ischemic stroke: A follow-up study with transcranial doppler. Stroke 1995: 26:430-433.
3. Mori E, Yoneda Y, Tabuchi M, et al. Intravenous recombinant tissue plasminogen activator in acute carotid artery territory stroke. Neurology 1992: 42:976-982.
4. Mobius E, Berg-dammar E, Kuhne D, Nahser HC. Local thrombolytic therapy in acute basilar artery occlusion: experience with 18 patients. In: Hacke W, del Zoppo GJ, Hirschenberg M, eds. Thrombolytic Therapy in Acute Ischemic Stroke. Heidelberg, Germany : Springer, 1991: 213-215.
5. Okada Y, Shima Y, Oki S, Uozumi T. Experimental micro-surgical embolectomy after middle cerebral artery embolization in the dog. Stroke 1983: 58:259-266.
6. Brott T. Thrombolytic therapy for stroke. Cerebrovasc Brain Metab Rev 1991: 3:91-113.
7. Pessin MS, del Zoppo GJ, Estol C. Thrombolytic agents in the treatment of stroke. Clin Neuropharmacol 1990: 13:271-289.
8. del Zoppo GJ, Pessin MS, Mori E, Hacke W. Thrombolytic intervention in acute thrombotic and embolic stroke. Se-min Neurol 1991: 11:368-384.
9. Ringelstein EB, Biniek R, Weiller C, Ammeling B, Nolte PN, Thron A. Type and extent of hemispheric brain infarctions and clinical outcome in early and delayed middle cerebral artery recanalization. Neurology 1992: 42:289-298.
10. Moil E. Fibrinolytic recanalization therapy in acute cerebrovascular thromboembolism. In: Hacke W, del Zoppo GJ, Hirschberg M, eds. Thrombolytic Therapy in Acute Ischemic Stroke. Heidelberg, Germany : Springer, 1991: 207-212.
11. von Kummer R, Hacks W. Safety and efficacy of intravenous tissue plasminogen activator and heparin in acute middle cerebral artery stroke. Stroke 1992: 23:646-652.
12. Yamaguchi Y, Hayakawa T, Kikuchi H, Abe T. Thrombolytic therapy in embolic and thrombotic cerebral infarction. In: Hacke W, del Zoppo GJ, Hirschberg M, eds. Thrombolytic Therapy in Acute Ischemic Stroke. Heidelberg, Germany : Springer, 1991: 168-174.
13. rt-PA/Acute stroke Study Group. An open safety/efficacy trial of rt-PA in acute thromboembolic stroke. Heidelberg, Germany: Springer, 1991: 22: 153. Abstract.
14. Brott TG, Haley EC, Levy DE, et al. Urgent therapy for stroke: part I. Pilot study of tissue plasminogen activator administered within 90 minutes. Stroke 1992: 23:632-640.
15. Haley EC, Levy DE, Brott TG, et al. Urgent therapy for stroke: part II. Pilot study of tissue plasminogen activator administered within 90-180 minutes from onset. Stroke 1992: 23:641-645.
16. Okada Y, Sadoshima S, Nakane H, Utsunomiya H, Fuji-shima M. Early computed tomographic findings for thrombolytic therapy in patients with acute brain embolism. Stroke 1992: 23:20-23.
17. Matsumoto K, Satoh K. Topical intraarterial urokinase infusion for acute stroke. In: Hacke W, del Zoppo GJ, Hirschberg M, eds. Thrombolytic Therapy in Acute Ischemic Stroke. Heidelberg, Germany : Springer, 1991: 207-212.
18. Mori E, Tabuchi M, Yoshida T, Yamadori A. Intracarotid urokinase with thromboembolic occlusion of the middle cerebral artery. Stroke 1988: 19:802-812.
19. Theron J, Courtheoux P, Casasco A, et al. Local intraarterial fibrinolysis in the carotid territory. AJNR 1989: 10:753-765.
20. Hacke W, Zeumer H, Ferbert A, Bruckmann H, del Zoppo GJ. Intra-arterial thrombolytic therapy improves outcome in patients with acute vertebrobasilar occlusion disease. Stroke 1988: 19:1216-1222.
21. Zeumer H. Fibronolytysis in cerebrovascular diseases of the central nervous system. In: Vinuela F, et al., eds. Interventional Neuroradiology: Endovascular Therapy of the Central Nervous System. New York : Raven Press, 1992: 141-151.
22. del Zoppo GJ, Ferbert A, Otis S, et al. Local intra-arterial fibrinolytic therapy in acute carotid territory stroke. Stroke 1988: 19:307-313.
23. Hughes RL, Yonas H, Gur D, Latchaw R. Cerebral blood flow determination within the first 8 hours of cerebral infarction using stable xenon-enhanced computed tomography. Stroke 1989: 20:754-760.
24. Sato H, Sakurai Y, Niizuma H, Kayama T, Ogawa A. Cerebral blood flow determination within the first few hours of acute embolic infarction. In: Yonas H, ed. Cerebral blood flow measurement with stable xenon-enhanced computed tomography. New York : Raven Press, 1992: 114-120.
25. Giubilei F, Lenzi GL, Di piero V, et al. Predictive value of brain perfusion single-photon emission computed tomography in acute ischemic stroke. Stroke 1990: 21:895-900.
26. Ueda T, Hatakeyama T, Kumon Y, Sakaki S, Uraoka T. Evaluation of risk of hemorrhagic transformation in local intra-arterial thrombolysis in acute ischemic stroke by initial SPECT. Stroke 1994: 25:298-303.
27. Baird AE, Donnan GA, Austin MC, Fitt GJ, Davis SM, Mckay WJ. Reperfusion after thrombolytic therapy in ischemic stroke measured by single-photon emission computed tomography. Stroke 1994: 25:79-85.
28. Gur D, Yonas H, Jackson DL, et al. Simultaneous measurement of cerebral blood flow by the xenon/CT method and the microsphere method. Invest Radiol 1985: 20:672-677.
29. Yonas H, Wolfson SKJ, Gur D, et al. Clinical experience with the use of xenon-enhanced CT blood flow mapping in cerebral vascular disease. Stroke 1984: 15:443-450.
30. Yonas H, Good WF, Gur D, et al. Mapping cerebral blood flow by xenon-enhanced tomography: Clinical experience. Radiology 1984: 152:435-442.
31. Meyer JS, Okayasu H, Tachibana H, Okabe T. Stable xenon CT CBF measurement in prevalent cerebrovascular disease (stroke). Stroke 1984: 15:80-90.
32. Marchal G, Serrati C, Rloux P, et al. PET imaging of cerebral perfusion and oxygen consumption in acute ischemic stroke: relation to outcome. Lancet 1993: 341:925-927.
33. Zeumer H. Vascular recanalizing techniques in interventional neuroradiology. J Neurol 1985: 231:287-294.
34. Caplan L, Babikian V, Helgason C, et al. Occlusive disease of the middle cerebral artery. Neurology 1985: 35:975-982.
35. Smith HA, Thompson-dobkin J, Yonas H, Flint E. Correlation of xenon-enhanced tomography-defined cerebral blood flow reactivity and collateral flow pattern. Stroke 1994: 25:1784-1787.
36. Yonas H, Smith HA, Durham SR, Pentheny SL, Johonson DW. Increased stroke risk predicted by compromised cerebral blood flow reactivity. J Neurosurg 1993: 79:483-489.
37. Yamashita T, Kashiwagi S, Nakano S, et al. Selecting patients for extracranial-intracranial bypass using Xe/CT blood flow studies and the Diamox test. In: Yonas H, ed. Cerebral blood flow measurement with stable xenon-en-hanced computed tomography. New York : Raven Press, 1992: 162-169.
38. Levy DE, Brott TG, Haley JR C, et al. Factors related to intracranial hematoma information in patients receiving tissue-type plasminogen activator for acute ischemic stroke. Stroke 1994: 25:291-297.